• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病脑血管和老年斑核心淀粉样沉积物的肽组成。

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

作者信息

Miller D L, Papayannopoulos I A, Styles J, Bobin S A, Lin Y Y, Biemann K, Iqbal K

机构信息

New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314.

出版信息

Arch Biochem Biophys. 1993 Feb 15;301(1):41-52. doi: 10.1006/abbi.1993.1112.

DOI:10.1006/abbi.1993.1112
PMID:8442665
Abstract

The pathological findings of Alzheimer's disease include amyloid deposition in cerebral blood vessels and in senile plaques. Both deposits are known to include peptides that contain a common sequence. Both forms of amyloid were isolated and their peptide compositions were determined. The peptides were resolved by size-exclusion chromatography in 70% formic acid, and reverse-phase chromatography in 60% formic acid, 0-40% acetonitrile. Senile plaque amyloid cores contain about 25% protein, about 70% of which is composed of peptides containing the beta-amyloid sequence. Amino-terminal sequencing of the core amyloid peptides (CAPs) revealed extensive amino-terminal heterogeneity, with variable amounts of blocked amino termini. Matrix-assisted, laser-desorption-time-of-flight mass spectrometry of the CAP mixture revealed an array of peptides the molecular weights of which corresponded to peptides beginning with each of the first 11 amino acids of the beta-peptide sequence and ending with Ala-42 of that sequence. The carboxyl-terminal residues were identified by tandem mass spectrometry of chymotrypsin digests. CAP possessed a minor degree of carboxyl-terminal heterogeneity. Cerebrovascular amyloid peptides (CVAPs) possessed minor degrees of both amino- and carboxyl-terminal heterogeneity. The major CVAP commenced at Asp-1 and ended at Val-40. Minor components of CAP possessed masses of 8000-9000 Da and the same amino-terminal residues as the major components of CAP. They may be precursors to the smaller CAPs. The differences in amino termini and carboxyl termini of CAPs and CVAPs suggest that the two types of amyloid form by different pathways, on which they encounter different proteases.

摘要

阿尔茨海默病的病理发现包括脑血管和老年斑中的淀粉样蛋白沉积。已知这两种沉积物都包含含有共同序列的肽。两种形式的淀粉样蛋白都被分离出来,并确定了它们的肽组成。这些肽通过在70%甲酸中的尺寸排阻色谱法以及在60%甲酸、0 - 40%乙腈中的反相色谱法进行分离。老年斑淀粉样核心含有约25%的蛋白质,其中约70%由含有β-淀粉样序列的肽组成。核心淀粉样肽(CAPs)的氨基末端测序显示出广泛的氨基末端异质性,有不同数量的封闭氨基末端。CAP混合物的基质辅助激光解吸飞行时间质谱分析揭示了一系列肽,其分子量对应于以β-肽序列的前11个氨基酸中的每一个开始并以该序列的Ala - 42结束的肽。通过胰凝乳蛋白酶消化产物的串联质谱法鉴定了羧基末端残基。CAP具有较小程度的羧基末端异质性。脑血管淀粉样肽(CVAPs)在氨基末端和羧基末端都具有较小程度的异质性。主要的CVAP从Asp - 1开始,到Val - 40结束。CAP的次要成分的分子量为8,000 - 9,000 Da,并且与CAP的主要成分具有相同的氨基末端残基。它们可能是较小CAPs的前体。CAPs和CVAPs在氨基末端和羧基末端的差异表明这两种类型的淀粉样蛋白通过不同的途径形成,在这些途径中它们遇到不同的蛋白酶。

相似文献

1
Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.阿尔茨海默病脑血管和老年斑核心淀粉样沉积物的肽组成。
Arch Biochem Biophys. 1993 Feb 15;301(1):41-52. doi: 10.1006/abbi.1993.1112.
2
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.人源和PS2APP小鼠脑内淀粉样沉积物中β淀粉样肽组成的高灵敏度分析
Neuroscience. 2006 Dec 1;143(2):461-75. doi: 10.1016/j.neuroscience.2006.08.027. Epub 2006 Sep 27.
3
Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.液相色谱/串联质谱法对氧化淀粉样β肽作为阿尔茨海默病潜在生物标志物的表征
Rapid Commun Mass Spectrom. 2006;20(5):911-8. doi: 10.1002/rcm.2395.
4
Amyloid beta protein and the basis for Alzheimer's disease.β-淀粉样蛋白与阿尔茨海默病的发病基础。
Prog Clin Biol Res. 1989;317:857-68.
5
On-line high-performance liquid chromatography/mass spectrometric investigation of amyloid-beta peptide variants found in Alzheimer's disease.在线高效液相色谱/质谱法对阿尔茨海默病中发现的β-淀粉样肽变体的研究。
Rapid Commun Mass Spectrom. 1999;13(23):2348-51. doi: 10.1002/(SICI)1097-0231(19991215)13:23<2348::AID-RCM797>3.0.CO;2-J.
6
[The pathogenesis of Alzheimer's disease demonstrated by immunocytochemistry with anti-beta-protein antibody].用抗β蛋白抗体免疫细胞化学法证明的阿尔茨海默病发病机制
Yakubutsu Seishin Kodo. 1992 Jun;12(3):141-9.
7
Analysis of single Alzheimer solid plaque cores by laser capture microscopy and nanoelectrospray/tandem mass spectrometry.通过激光捕获显微镜和纳米电喷雾/串联质谱法对单个阿尔茨海默病固体斑块核心进行分析。
Biochemistry. 2006 Aug 15;45(32):9849-56. doi: 10.1021/bi060331+.
8
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.唐氏综合征中异质性淀粉样β肽和载脂蛋白E的沉积顺序:对淀粉样斑块形成初始事件的影响。
Neurobiol Dis. 1996 Feb;3(1):16-32. doi: 10.1006/nbdi.1996.0003.
9
N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease.在阿尔茨海默病中检测淀粉样蛋白的N端异质性。
Int J Neurosci. 2004 Jan;114(1):75-81. doi: 10.1080/00207450490249455.
10
Cleavage of a beta-amyloid precursor sequence by cathepsin D.组织蛋白酶D对β-淀粉样前体序列的切割
Biomed Pept Proteins Nucleic Acids. 1995;1(4):243-6.

引用本文的文献

1
Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum.大脑中的异构化β淀粉样蛋白(Aβ)能够区分阿尔茨海默病谱系中淀粉样变性的状态。
Acta Neuropathol. 2025 Jul 22;150(1):7. doi: 10.1007/s00401-025-02914-2.
2
Extracellular Vesicles and Purinergic Signaling in Alzheimer's Disease-Joining Forces for Novel Therapeutic Approach.阿尔茨海默病中的细胞外囊泡与嘌呤能信号传导——携手探索新型治疗方法
Brain Sci. 2025 May 26;15(6):570. doi: 10.3390/brainsci15060570.
3
Towards early diagnosis and screening of Alzheimer's disease using frequency locked whispering gallery mode microtoroids.
利用频率锁定回音壁模式微环实现阿尔茨海默病的早期诊断和筛查
NPJ Biosens. 2024;1(1):9. doi: 10.1038/s44328-024-00009-8. Epub 2024 Aug 28.
4
Chemical imaging delineates Aβ plaque polymorphism across the Alzheimer's disease spectrum.化学成像描绘了阿尔茨海默病谱系中的β淀粉样蛋白斑块多态性。
Nat Commun. 2025 Apr 24;16(1):3889. doi: 10.1038/s41467-025-59085-7.
5
Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review.脑淀粉样血管病的血浆生物标志物及其对淀粉样相关影像学异常的影响:综述
J Clin Med. 2025 Feb 7;14(4):1070. doi: 10.3390/jcm14041070.
6
Alzheimer's Disease: In Vitro and In Vivo Evidence of Activation of the Plasma Bradykinin-Forming Cascade and Implications for Therapy.阿尔茨海默病:血浆缓激肽形成级联激活的体外和体内证据及其治疗意义。
Cells. 2024 Dec 10;13(24):2039. doi: 10.3390/cells13242039.
7
Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures.阿尔茨海默病中蛋白质聚集的诱导剂和调节剂——理解聚集体结构基础的关键工具。
Neurotherapeutics. 2025 Apr;22(3):e00512. doi: 10.1016/j.neurot.2024.e00512. Epub 2025 Jan 3.
8
Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons.解读载脂蛋白E在脑淀粉样血管病中的作用:从遗传学见解到治疗前景
Ann Med. 2025 Dec;57(1):2445194. doi: 10.1080/07853890.2024.2445194. Epub 2025 Jan 2.
9
Aggregation dynamics of a 150 kDa Aβ42 oligomer: Insights from cryo electron microscopy and multimodal analysis.150 kDa Aβ42寡聚体的聚集动力学:来自冷冻电子显微镜和多模态分析的见解
Comput Struct Biotechnol J. 2024 Nov 12;23:4205-4213. doi: 10.1016/j.csbj.2024.11.024. eCollection 2024 Dec.
10
Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.鉴定异天冬氨酸7-淀粉样蛋白(isoAsp7-Aβ)为阿尔茨海默病、路易体痴呆和血管性痴呆中的主要淀粉样蛋白变体。
Acta Neuropathol. 2024 Dec 3;148(1):78. doi: 10.1007/s00401-024-02824-9.